company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,22002000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,22002000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5284000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5284000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,16718000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,15753000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6653000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,367000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,22773000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6055000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,237000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,81000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,318000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5737000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,243000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5980000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5980000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5980000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,37400000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.16
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,37400000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.16
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,37086000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q1,2010-04-01,2010-06-30,2011-08-05 16:52:32+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.16
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,2011-11-07 16:58:31+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,23376000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,2011-11-07 16:58:31+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,23376000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,2011-11-07 16:58:31+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5408000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,2011-11-07 16:58:31+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5408000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,2011-11-07 16:58:31+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,17968000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,2011-11-07 16:58:31+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,14054000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,2011-11-07 16:58:31+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6589000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,2011-11-07 16:58:31+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,372000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,2011-11-07 16:58:31+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,21015000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,2011-11-07 16:58:31+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3047000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,2011-11-07 16:58:31+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,216000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,2011-11-07 16:58:31+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-128000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,2011-11-07 16:58:31+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,88000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,2011-11-07 16:58:31+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2959000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,2011-11-07 16:58:31+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,242000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,2011-11-07 16:58:31+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3201000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,2011-11-07 16:58:31+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3201000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,2011-11-07 16:58:31+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3201000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,2011-11-07 16:58:31+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,37156000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,2011-11-07 16:58:31+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.09
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,2011-11-07 16:58:31+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,37156000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q2,2010-07-01,2010-09-30,2011-11-07 16:58:31+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.09
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,2012-02-08 16:05:47+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,27244000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,2012-02-08 16:05:47+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,27244000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,2012-02-08 16:05:47+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5437000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,2012-02-08 16:05:47+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5437000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,2012-02-08 16:05:47+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,21807000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,2012-02-08 16:05:47+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,15592000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,2012-02-08 16:05:47+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6592000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,2012-02-08 16:05:47+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,295000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,2012-02-08 16:05:47+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,22479000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,2012-02-08 16:05:47+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-672000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,2012-02-08 16:05:47+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,4000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,2012-02-08 16:05:47+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,30000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,2012-02-08 16:05:47+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,34000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,2012-02-08 16:05:47+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-638000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,2012-02-08 16:05:47+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,164000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,2012-02-08 16:05:47+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-802000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,2012-02-08 16:05:47+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-802000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,2012-02-08 16:05:47+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-802000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,2012-02-08 16:05:47+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,37195000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,2012-02-08 16:05:47+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.02
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,2012-02-08 16:05:47+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,37195000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q3,2010-10-01,2010-12-31,2012-02-08 16:05:47+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.02
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,28529000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,28529000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5848000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5848000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,22681000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,16888000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6843000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,361000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,24092000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1411000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,8000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-126000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-118000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1529000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,243000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1772000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1772000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1772000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,37167000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.05
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,37167000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.05
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,36700000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2011.0,Q4,2011-01-01,2011-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.16
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,27355000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,27355000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5891000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5891000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,21464000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,18176000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7324000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,385000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,25885000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4421000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,4000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-81000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-77000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4498000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,96000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4594000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4594000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4594000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,38268000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.12
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,38268000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.12
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,38300000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q1,2011-04-01,2011-06-30,2012-08-06 16:05:42+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.12
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,2012-11-05 16:26:46+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,29478000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,2012-11-05 16:26:46+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,29478000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,2012-11-05 16:26:46+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5551000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,2012-11-05 16:26:46+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5551000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,2012-11-05 16:26:46+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,23927000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,2012-11-05 16:26:46+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,16323000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,2012-11-05 16:26:46+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6459000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,2012-11-05 16:26:46+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,379000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,2012-11-05 16:26:46+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,23161000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,2012-11-05 16:26:46+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,766000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,2012-11-05 16:26:46+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-6000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,2012-11-05 16:26:46+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,66000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,2012-11-05 16:26:46+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,60000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,2012-11-05 16:26:46+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,826000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,2012-11-05 16:26:46+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,225000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,2012-11-05 16:26:46+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,601000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,2012-11-05 16:26:46+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,601000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,2012-11-05 16:26:46+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,601000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,2012-11-05 16:26:46+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,38256000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,2012-11-05 16:26:46+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.02
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,2012-11-05 16:26:46+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,39366000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,2012-11-05 16:26:46+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.02
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,2012-11-05 16:26:46+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,30100000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q2,2011-07-01,2011-09-30,2012-11-05 16:26:46+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.02
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,2013-02-06 10:43:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,32198000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,2013-02-06 10:43:54+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,32198000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,2013-02-06 10:43:54+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6279000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,2013-02-06 10:43:54+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6279000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,2013-02-06 10:43:54+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,25919000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,2013-02-06 10:43:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,17184000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,2013-02-06 10:43:54+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6140000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,2013-02-06 10:43:54+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,362000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,2013-02-06 10:43:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,23686000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,2013-02-06 10:43:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2233000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,2013-02-06 10:43:54+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1015000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,2013-02-06 10:43:54+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,39000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,2013-02-06 10:43:54+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1054000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,2013-02-06 10:43:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3287000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,2013-02-06 10:43:54+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,366000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,2013-02-06 10:43:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2921000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,2013-02-06 10:43:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2921000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,2013-02-06 10:43:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2921000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,2013-02-06 10:43:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,38498000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,2013-02-06 10:43:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.08
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,2013-02-06 10:43:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,40270000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,2013-02-06 10:43:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.07
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,2013-02-06 10:43:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,36500000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q3,2011-10-01,2011-12-31,2013-02-06 10:43:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.08
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,37344000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,37344000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6786000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6786000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,30558000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,20028000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7236000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,352000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,27616000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2942000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-15000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-14000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2928000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,361000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2567000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2567000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2567000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,38374000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.06
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,40172000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.07
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,37400000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2012.0,Q4,2012-01-01,2012-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.06
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,38783000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,38783000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,7446000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,7446000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,31337000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,20953000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6712000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,111000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,27776000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3561000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-2000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-4000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-6000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3555000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,436000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3119000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3119000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3119000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,39144000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.08
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41549000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.08
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,39000000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q1,2012-04-01,2012-06-30,2013-08-07 16:09:53+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.08
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,2013-11-08 14:17:52+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,37417000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,2013-11-08 14:17:52+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,37417000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,2013-11-08 14:17:52+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,7194000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,2013-11-08 14:17:52+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,7194000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,2013-11-08 14:17:52+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,30223000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,2013-11-08 14:17:52+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,18437000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,2013-11-08 14:17:52+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5854000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,2013-11-08 14:17:52+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,24291000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,2013-11-08 14:17:52+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5932000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,2013-11-08 14:17:52+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,2013-11-08 14:17:52+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-9000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,2013-11-08 14:17:52+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-8000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,2013-11-08 14:17:52+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5924000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,2013-11-08 14:17:52+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,455000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,2013-11-08 14:17:52+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5469000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,2013-11-08 14:17:52+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5469000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,2013-11-08 14:17:52+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5469000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,2013-11-08 14:17:52+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,39431000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,2013-11-08 14:17:52+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.14
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,2013-11-08 14:17:52+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41722000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,2013-11-08 14:17:52+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.13
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,2013-11-08 14:17:52+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,39100000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q2,2012-07-01,2012-09-30,2013-11-08 14:17:52+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.14
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,2014-02-06 16:05:53+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,38250000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,2014-02-06 16:05:53+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,38250000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,2014-02-06 16:05:53+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,8130000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,2014-02-06 16:05:53+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,8130000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,2014-02-06 16:05:53+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,30120000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,2014-02-06 16:05:53+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,20943000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,2014-02-06 16:05:53+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6259000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,2014-02-06 16:05:53+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,27202000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,2014-02-06 16:05:53+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2918000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,2014-02-06 16:05:53+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,2014-02-06 16:05:53+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,324000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,2014-02-06 16:05:53+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,325000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,2014-02-06 16:05:53+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3243000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,2014-02-06 16:05:53+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,559000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,2014-02-06 16:05:53+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2684000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,2014-02-06 16:05:53+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2684000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,2014-02-06 16:05:53+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2684000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,2014-02-06 16:05:53+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,39417000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,2014-02-06 16:05:53+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.07
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,2014-02-06 16:05:53+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,40865000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,2014-02-06 16:05:53+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.07
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,2014-02-06 16:05:53+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,38300000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q3,2012-10-01,2012-12-31,2014-02-06 16:05:53+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.07
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,43674000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,43674000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,8826000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,8826000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,34848000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,23894000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6822000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,30716000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4132000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-7000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,15000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,8000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4140000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,398000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3742000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3742000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3742000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,39113000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.09
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41052000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.09
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,39500000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2013.0,Q4,2013-01-01,2013-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.09
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,42670000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,42670000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,8723000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,8723000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,33947000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,27967000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7287000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,35254000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1307000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,16000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-21000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1312000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,411000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1723000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1723000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1723000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,38678000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.04
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,38678000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.04
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,43100000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q1,2013-04-01,2013-06-30,2014-08-06 12:52:56+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.04
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,2014-11-10 14:36:59+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,44345000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,2014-11-10 14:36:59+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,44345000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,2014-11-10 14:36:59+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,9027000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,2014-11-10 14:36:59+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,9027000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,2014-11-10 14:36:59+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,35318000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,2014-11-10 14:36:59+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,26199000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,2014-11-10 14:36:59+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7721000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,2014-11-10 14:36:59+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,33920000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,2014-11-10 14:36:59+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1398000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,2014-11-10 14:36:59+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,25000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,2014-11-10 14:36:59+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,6000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,2014-11-10 14:36:59+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,31000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,2014-11-10 14:36:59+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1429000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,2014-11-10 14:36:59+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,370000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,2014-11-10 14:36:59+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1059000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,2014-11-10 14:36:59+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1059000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,2014-11-10 14:36:59+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1059000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,2014-11-10 14:36:59+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,39260000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,2014-11-10 14:36:59+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.03
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,2014-11-10 14:36:59+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41337000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,2014-11-10 14:36:59+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.03
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,2014-11-10 14:36:59+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,35300000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q2,2013-07-01,2013-09-30,2014-11-10 14:36:59+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.03
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,2015-01-30 15:00:24+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,46195000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,2015-01-30 15:00:24+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,46195000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,2015-01-30 15:00:24+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,9458000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,2015-01-30 15:00:24+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,9458000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,2015-01-30 15:00:24+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,36737000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,2015-01-30 15:00:24+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,24364000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,2015-01-30 15:00:24+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7779000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,2015-01-30 15:00:24+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,32143000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,2015-01-30 15:00:24+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4594000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,2015-01-30 15:00:24+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,37000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,2015-01-30 15:00:24+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,20000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,2015-01-30 15:00:24+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,57000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,2015-01-30 15:00:24+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4651000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,2015-01-30 15:00:24+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,258000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,2015-01-30 15:00:24+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4393000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,2015-01-30 15:00:24+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4393000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,2015-01-30 15:00:24+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4393000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,2015-01-30 15:00:24+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,39592000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,2015-01-30 15:00:24+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.11
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,2015-01-30 15:00:24+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41726000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,2015-01-30 15:00:24+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.11
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,2015-01-30 15:00:24+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,39900000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q3,2013-10-01,2013-12-31,2015-01-30 15:00:24+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.11
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,50433000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,50433000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,10114000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,10114000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,40319000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,28721000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7920000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,36641000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3678000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,40000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,44000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,84000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3762000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,140000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3622000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3622000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3622000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,39334000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.09
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41606000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.08
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,38700000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2014.0,Q4,2014-01-01,2014-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.09
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,48811000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,48811000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,9689000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,9689000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,39122000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,31598000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9062000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,40660000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1538000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,44000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,11000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,55000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1483000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,226000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1709000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1709000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1709000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,40062000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.04
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,40062000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.04
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,42700000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q1,2014-04-01,2014-06-30,2015-08-06 16:17:24+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.04
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,2015-11-04 16:06:42+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,51938000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,2015-11-04 16:06:42+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,51938000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,2015-11-04 16:06:42+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,9612000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,2015-11-04 16:06:42+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,9612000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,2015-11-04 16:06:42+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,42326000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,2015-11-04 16:06:42+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,29455000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,2015-11-04 16:06:42+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8693000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,2015-11-04 16:06:42+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,38148000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,2015-11-04 16:06:42+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4178000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,2015-11-04 16:06:42+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,36000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,2015-11-04 16:06:42+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-39000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,2015-11-04 16:06:42+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,2015-11-04 16:06:42+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4175000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,2015-11-04 16:06:42+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,336000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,2015-11-04 16:06:42+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3839000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,2015-11-04 16:06:42+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3839000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,2015-11-04 16:06:42+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3839000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,2015-11-04 16:06:42+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,40448000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,2015-11-04 16:06:42+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.09
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,2015-11-04 16:06:42+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,42239000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,2015-11-04 16:06:42+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.09
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,2015-11-04 16:06:42+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,42700000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q2,2014-07-01,2014-09-30,2015-11-04 16:06:42+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.09
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,2016-02-05 16:08:32+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,62005000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,2016-02-05 16:08:32+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,62005000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,2016-02-05 16:08:32+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,9838000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,2016-02-05 16:08:32+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,9838000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,2016-02-05 16:08:32+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,52167000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,2016-02-05 16:08:32+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,30139000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,2016-02-05 16:08:32+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8365000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,2016-02-05 16:08:32+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,38504000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,2016-02-05 16:08:32+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,13663000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,2016-02-05 16:08:32+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,48000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,2016-02-05 16:08:32+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-10000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,2016-02-05 16:08:32+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,38000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,2016-02-05 16:08:32+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,13701000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,2016-02-05 16:08:32+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1017000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,2016-02-05 16:08:32+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,12684000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,2016-02-05 16:08:32+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,12684000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,2016-02-05 16:08:32+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,12684000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,2016-02-05 16:08:32+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,40856000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,2016-02-05 16:08:32+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.31
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,2016-02-05 16:08:32+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,42884000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,2016-02-05 16:08:32+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.3
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,2016-02-05 16:08:32+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,40900000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q3,2014-10-01,2014-12-31,2016-02-05 16:08:32+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.31
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,67557000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,67557000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,10806000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,10806000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,56751000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,34535000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9853000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,44388000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,12363000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,68000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-59000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,9000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,12372000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-86502000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,98874000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,98874000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,98874000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,40632000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.44
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,42858000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.3
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,40600000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2015.0,Q4,2015-01-01,2015-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.44
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,73432000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,73432000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,10868000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,10868000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,62564000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,37323000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10210000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,47533000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,15031000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,63000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,53000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,116000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,15147000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,6288000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8859000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,8859000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,8859000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,41696000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.21
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,44410000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.2
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,42200000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q1,2015-04-01,2015-06-30,2016-08-03 15:08:34+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.21
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,2016-11-04 16:16:24+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,76359000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,2016-11-04 16:16:24+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,76359000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,2016-11-04 16:16:24+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,12144000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,2016-11-04 16:16:24+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,12144000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,2016-11-04 16:16:24+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,64215000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,2016-11-04 16:16:24+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,39829000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,2016-11-04 16:16:24+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11569000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,2016-11-04 16:16:24+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,51398000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,2016-11-04 16:16:24+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,12817000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,2016-11-04 16:16:24+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,62000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,2016-11-04 16:16:24+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,87000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,2016-11-04 16:16:24+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,149000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,2016-11-04 16:16:24+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,12966000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,2016-11-04 16:16:24+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,5231000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,2016-11-04 16:16:24+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7735000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,2016-11-04 16:16:24+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,7735000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,2016-11-04 16:16:24+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7735000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,2016-11-04 16:16:24+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,42228000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,2016-11-04 16:16:24+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.18
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,2016-11-04 16:16:24+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,44922000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,2016-11-04 16:16:24+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.17
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,2016-11-04 16:16:24+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,43000000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q2,2015-07-01,2015-09-30,2016-11-04 16:16:24+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.18
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,2017-02-03 16:06:37+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,85795000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,2017-02-03 16:06:37+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,85795000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,2017-02-03 16:06:37+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,12744000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,2017-02-03 16:06:37+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,12744000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,2017-02-03 16:06:37+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,73051000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,2017-02-03 16:06:37+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,41853000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,2017-02-03 16:06:37+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,13755000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,2017-02-03 16:06:37+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,55608000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,2017-02-03 16:06:37+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,17443000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,2017-02-03 16:06:37+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,84000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,2017-02-03 16:06:37+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-29000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,2017-02-03 16:06:37+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,55000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,2017-02-03 16:06:37+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,17498000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,2017-02-03 16:06:37+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,6943000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,2017-02-03 16:06:37+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,10555000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,2017-02-03 16:06:37+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,10555000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,2017-02-03 16:06:37+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,10555000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,2017-02-03 16:06:37+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,42427000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,2017-02-03 16:06:37+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.25
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,2017-02-03 16:06:37+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,44949000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,2017-02-03 16:06:37+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.23
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,2017-02-03 16:06:37+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,42200000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q3,2015-10-01,2015-12-31,2017-02-03 16:06:37+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.25
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,93957000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,93957000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,14663000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,14663000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,79294000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,45256000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14225000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,59481000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,19813000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,186000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,228000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,414000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,20227000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,9229000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,10998000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,10998000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,10998000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,42204000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.26
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,44895000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.25
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,42400000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2016.0,Q4,2016-01-01,2016-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.26
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,102995000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,102995000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,15070000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,15070000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,87925000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,51032000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,15660000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,66692000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,21233000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,269000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-77000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,192000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,21425000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,8515000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,12910000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,12910000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,12910000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,42811000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.3
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,45178000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.29
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,43000000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q1,2016-04-01,2016-06-30,2017-08-01 15:06:52+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.3
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,2017-11-02 16:33:06+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,102955000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,2017-11-02 16:33:06+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,102955000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,2017-11-02 16:33:06+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,17309000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,2017-11-02 16:33:06+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,17309000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,2017-11-02 16:33:06+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,85646000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,2017-11-02 16:33:06+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,53086000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,2017-11-02 16:33:06+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,18052000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,2017-11-02 16:33:06+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,71138000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,2017-11-02 16:33:06+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,14508000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,2017-11-02 16:33:06+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,342000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,2017-11-02 16:33:06+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-114000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,2017-11-02 16:33:06+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,228000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,2017-11-02 16:33:06+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,14736000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,2017-11-02 16:33:06+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,5861000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,2017-11-02 16:33:06+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8875000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,2017-11-02 16:33:06+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,8875000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,2017-11-02 16:33:06+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,8875000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,2017-11-02 16:33:06+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,43129000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,2017-11-02 16:33:06+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.21
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,2017-11-02 16:33:06+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,44580000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,2017-11-02 16:33:06+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.2
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,2017-11-02 16:33:06+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,42300000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q2,2016-07-01,2016-09-30,2017-11-02 16:33:06+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.21
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,2018-02-06 16:23:49+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,114674000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,2018-02-06 16:23:49+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,114674000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,2018-02-06 16:23:49+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,18987000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,2018-02-06 16:23:49+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,18987000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,2018-02-06 16:23:49+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,95687000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,2018-02-06 16:23:49+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,53935000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,2018-02-06 16:23:49+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,16349000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,2018-02-06 16:23:49+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,70284000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,2018-02-06 16:23:49+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,25403000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,2018-02-06 16:23:49+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,457000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,2018-02-06 16:23:49+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-34000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,2018-02-06 16:23:49+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,423000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,2018-02-06 16:23:49+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,25826000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,2018-02-06 16:23:49+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,10394000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,2018-02-06 16:23:49+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,15432000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,2018-02-06 16:23:49+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,15432000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,2018-02-06 16:23:49+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,15432000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,2018-02-06 16:23:49+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,43431000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,2018-02-06 16:23:49+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.36
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,2018-02-06 16:23:49+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,44770000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,2018-02-06 16:23:49+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.34
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,2018-02-06 16:23:49+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,42900000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q3,2016-10-01,2016-12-31,2018-02-06 16:23:49+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.36
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,124680000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,124680000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,19261000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,19261000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,105419000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,60100000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,16325000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,76425000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,28994000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,486000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-124000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,362000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,29356000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,14457000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,14899000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,14899000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,14899000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,43238000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.34
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,44658000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.34
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,43100000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2017.0,Q4,2017-01-01,2017-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.34
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,132468000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,132468000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,21862000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,21862000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,110606000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,60597000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,16931000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,77528000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,33078000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,635000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,79000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,714000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,33792000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-3582000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,37374000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,37374000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,37374000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,43895000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.85
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,45608000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.82
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,44000000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q1,2017-04-01,2017-06-30,2018-08-02 13:45:58+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.85
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,2018-11-06 16:01:45+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,132823000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,2018-11-06 16:01:45+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,132823000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,2018-11-06 16:01:45+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,21627000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,2018-11-06 16:01:45+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,21627000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,2018-11-06 16:01:45+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,111196000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,2018-11-06 16:01:45+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,60080000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,2018-11-06 16:01:45+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,19390000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,2018-11-06 16:01:45+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,79470000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,2018-11-06 16:01:45+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,31726000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,2018-11-06 16:01:45+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,781000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,2018-11-06 16:01:45+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-23000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,2018-11-06 16:01:45+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,758000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,2018-11-06 16:01:45+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,32484000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,2018-11-06 16:01:45+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,7981000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,2018-11-06 16:01:45+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,24503000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,2018-11-06 16:01:45+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,24503000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,2018-11-06 16:01:45+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,24503000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,2018-11-06 16:01:45+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,44141000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,2018-11-06 16:01:45+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.56
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,2018-11-06 16:01:45+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,45698000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,2018-11-06 16:01:45+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.54
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,2018-11-06 16:01:45+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,43800000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q2,2017-07-01,2017-09-30,2018-11-06 16:01:45+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.56
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,2019-02-05 16:29:42+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,154022000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,2019-02-05 16:29:42+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,154022000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,2019-02-05 16:29:42+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,24994000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,2019-02-05 16:29:42+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,24994000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,2019-02-05 16:29:42+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,129028000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,2019-02-05 16:29:42+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,66556000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,2019-02-05 16:29:42+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,17706000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,2019-02-05 16:29:42+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,84262000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,2019-02-05 16:29:42+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,44766000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,2019-02-05 16:29:42+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,969000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,2019-02-05 16:29:42+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-81000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,2019-02-05 16:29:42+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,888000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,2019-02-05 16:29:42+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,45654000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,2019-02-05 16:29:42+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,32208000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,2019-02-05 16:29:42+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,13446000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,2019-02-05 16:29:42+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,13446000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,2019-02-05 16:29:42+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,13446000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,2019-02-05 16:29:42+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,44247000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,2019-02-05 16:29:42+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.3
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,2019-02-05 16:29:42+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,45869000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,2019-02-05 16:29:42+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.29
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,2019-02-05 16:29:42+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,44800000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q3,2017-10-01,2017-12-31,2019-02-05 16:29:42+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.3
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,174436000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,174436000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,30098000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,30098000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,144338000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,75501000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,21270000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,96771000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,47567000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1303000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-363000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,940000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,48507000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,11660000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,36847000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,36847000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,36847000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,44153000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.83
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,45849000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.8
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,44200000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2018.0,Q4,2018-01-01,2018-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.83
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,180010000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,180010000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,30850000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,30850000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,149160000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,81139000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,21273000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,102412000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,46748000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1551000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,188000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1739000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,48487000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-41600000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,90087000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,90066000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,90066000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,44546000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.02
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,46169000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.95
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,44600000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q1,2018-04-01,2018-06-30,2019-08-01 16:07:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.02
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,2019-10-31 16:13:44+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,181778000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,2019-10-31 16:13:44+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,181778000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,2019-10-31 16:13:44+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,29846000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,2019-10-31 16:13:44+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,29846000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,2019-10-31 16:13:44+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,151932000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,2019-10-31 16:13:44+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,78895000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,2019-10-31 16:13:44+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,22717000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,2019-10-31 16:13:44+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,101612000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,2019-10-31 16:13:44+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,50320000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,2019-10-31 16:13:44+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1671000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,2019-10-31 16:13:44+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-158000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,2019-10-31 16:13:44+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1513000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,2019-10-31 16:13:44+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,51833000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,2019-10-31 16:13:44+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1700000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,2019-10-31 16:13:44+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,50133000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,2019-10-31 16:13:44+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,50127000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,2019-10-31 16:13:44+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,50127000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,2019-10-31 16:13:44+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,44961000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,2019-10-31 16:13:44+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.11
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,2019-10-31 16:13:44+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,46153000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,2019-10-31 16:13:44+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.09
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,2019-10-31 16:13:44+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,45200000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q2,2018-07-01,2018-09-30,2019-10-31 16:13:44+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.11
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,2020-02-06 16:07:42+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,200563000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,2020-02-06 16:07:42+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,200563000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,2020-02-06 16:07:42+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,34023000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,2020-02-06 16:07:42+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,34023000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,2020-02-06 16:07:42+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,166540000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,2020-02-06 16:07:42+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,80220000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,2020-02-06 16:07:42+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,23965000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,2020-02-06 16:07:42+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,104185000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,2020-02-06 16:07:42+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,62355000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,2020-02-06 16:07:42+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2175000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,2020-02-06 16:07:42+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-20000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,2020-02-06 16:07:42+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2155000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,2020-02-06 16:07:42+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,64510000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,2020-02-06 16:07:42+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,19648000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,2020-02-06 16:07:42+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,44862000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,2020-02-06 16:07:42+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,44862000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,2020-02-06 16:07:42+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,44862000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,2020-02-06 16:07:42+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,45046000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,2020-02-06 16:07:42+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,2020-02-06 16:07:42+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,46136000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,2020-02-06 16:07:42+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.97
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,2020-02-06 16:07:42+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,44900000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q3,2018-10-01,2018-12-31,2020-02-06 16:07:42+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,207081000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,207081000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,34848000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,34848000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,172233000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,81296000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,25548000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,106844000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,65389000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2769000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,30372000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,33141000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,98530000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,24596000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,73934000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,73961000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,73961000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,44911000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.64
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,46151000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.6
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,44900000.0
Abiomed Inc,ABMD,5493001EZN4ZTB4Z5887,0000815094,2019.0,Q4,2019-01-01,2019-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.64
